bioAffinity Technologies

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BIAF and other ETFs, options, and stocks.

About BIAF

bioAffinity Technologies, Inc. operates as a development-stage company addressing the significant unmet need for non-invasive, early-stage cancer diagnosis and treatment. The firm develops proprietary in-vitro diagnostic tests and targeted cancer therapeutics using breakthrough technology that preferentially targets cancer cells. 

CEO
Maria Zannes
CEOMaria Zannes
Employees
57
Employees57
Headquarters
San Antonio, Texas
HeadquartersSan Antonio, Texas
Founded
2014
Founded2014
Employees
57
Employees57

BIAF Key Statistics

Market cap
5.59M
Market cap5.59M
Price-Earnings ratio
-0.09
Price-Earnings ratio-0.09
Dividend yield
Dividend yield
Average volume
7.14M
Average volume7.14M
High today
$12.46
High today$12.46
Low today
$8.25
Low today$8.25
Open price
$10.75
Open price$10.75
Volume
10.39M
Volume10.39M
52 Week high
$109.35
52 Week high$109.35
52 Week low
$4.56
52 Week low$4.56

Stock Snapshot

bioAffinity Technologies(BIAF) stock is priced at $8.75, giving the company a market capitalization of 5.59M. It carries a P/E multiple of -0.09.

On 2026-09-20, bioAffinity Technologies(BIAF) stock moved within a range of $8.25 to $12.46. With shares now at $8.75, the stock is trading +6.1% above its intraday low and -29.7% below the session's peak.

Trading volume for bioAffinity Technologies(BIAF) stock has reached 10.39M, versus its average volume of 7.14M.

Over the past 52 weeks, bioAffinity Technologies(BIAF) stock has traded between a high of $109.35 and a low of $4.56.

Over the past 52 weeks, bioAffinity Technologies(BIAF) stock has traded between a high of $109.35 and a low of $4.56.

BIAF News

TipRanks 3d
bioAffinity secures Hong Kong patent for CyPath Lung

bioAffinity Technologies, Inc. ( (BIAF) ) just unveiled an update. On September 17, 2026, bioAffinity Technologies announced that Hong Kong’s Intellectual Prop...

TipRanks 3d
BioAffinity Technologies announces grant of Hong Kong patent for CyPath Lung

bioAffinity Technologies (BIAF) announced that the Hong Kong Intellectual Property Department has granted a patent for the Company’s proprietary platform techno...

People also own

Based on the portfolios of people who own BIAF. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.